骨髓組織化生 的英文怎麼說

中文拼音 [gǔsuǐzǔzhīhuàshēng]
骨髓組織化生 英文
myeloid metaplasis
  • 骨 : 骨名詞1 （骨頭） bone2 （物體內部的支架） framework; skeleton 3 （品質; 氣概） character; spirit ...
  • 髓 : 名詞1. [生理學] （骨髓; 像骨髓的東西） marrow 2. [植物] （莖的中心部分） pith
  • 組 : Ⅰ名詞1 （由不多的人員組成的單位） group 2 （姓氏） a surname Ⅱ動詞（組織） organize; form Ⅲ量詞（...
  • 織 : 動詞（編織） knit; weave
  • 生 : Ⅰ動詞1 （生育; 生殖） give birth to; bear 2 （出生） be born 3 （生長） grow 4 （生存; 活） live;...
  • 骨髓 : marrow; keest; medulla ossium; bone marrow骨髓白細胞 myeloplast; 骨髓病 myelopathy; myelopthy; os...
  • 組織化 : organization
  • 組織 : 1 （組織系統） organization; organized system 2 （組成） organize; form 3 [紡織] weave 4 [醫學] [...
  1. Deficiency of apoe may promote to produce and develop atherosclerotic lessions. the apoe gene - targeted mice will result in marked regression of both early and advanced atherosclerotic lesions by injected apoe recombinant protein, or by transfected adviral vector with apoe cdna to express human apoe transgene in liver, or by transplantation of bone marrow with normal rat apoe gene. this demonstrates that apoe gene and its expressing product can inhibit progression of atherogenesis. apoe3 has a more effective prevention from as than apoe2 and apoe4

    Apoe的缺失可促進動脈粥樣硬化的發生發展，給apoe基因敲除鼠反復注射apoe重組蛋白、在肝組織中用腺病毒載體表達apoe蛋白、移植帶有正常apoe基因的小鼠骨髓，都能使apoe基因敲除鼠的動脈粥樣硬化得到回復，表明apoe基因及其表達產物對動脈粥樣硬化的發生具有抑制作用， apoe _ 3對動脈硬化的阻抑作用要比apoe _ 2和apoe _ 4都明顯。
  2. In this report, we mainly covered the following aspects of " tissue organ regeneration and replication in situ " : 1 ) procedures of tissue organd regeneration and replication and replication in clnical practice ; 2 ) the discover and existence of potentiald regenerative cell ( prc ) ; 3 ) the proliferation, differentiation and regeneration law of potential law of potential regenerative cells ; 4 ) study procedure on tissue organ regeneration and replication from prcs in vitro based on the model of full skin organ regeneration in situ after extensive in vitro, set up the method and technology of searching life regenerative substance required in tissue organ regeneration and replication in situ. in this study, first, the whole human body is divided into 206 function units, which are the " tissue organ " in regeneration study. then the histology foundation of tissue organ regeneration and replication in situ is set up. in ordre to prove the existence of the potential regenerative cells and their potential baility and function, we established clinical tracking rechnique of skin organ regeneration in situ ; meanwhile, several tissue organ regeneration and replication in vitro models which represent different kinds of runctions were sucessfully set up, with all these techniques and models, we confirmed : 1 ) the existence, function and ability of pptemtoa regenerative cells ; 2 ) the importance of life regenerative substance ; 3 ) the feasibility of tissue organ regeneration and replication in situ ; 4 ) the big value of tissue organ regeneration and replication in situ in life science and medicine progerss. we also showed the possible foreground of capture cancer with this method and technologh. in this report, nearly 200 photographs of several tissue organ regeneration and replication in situ or in vitro demonstrated the whole process of tissue organ and big organ entities regeneration and replication from cells. the results of tissue organ regeneration and replication in situ mainly include : 1 ) whole skin organ regeneration and replication in situ ; 2 ) gastrointestinal mucosa tissue organ regeneration in vitro ; 3 ) hair follicle tissue organ regeneration in situ or in vitro ; 4 ) never tissue organ regeneration in situ ; 5 ) pancreas tissue organ regeneration and replication in vitro ; 5 ) marrow tissue regeneration in vitro ; 6 ) renal glomerulus and tubule tissue organ tugeneraation in vitro ; 7 ) heart muscle regeneration in vitro, etcl. in order to let more and more people know and understand this technology of tissue organd regeneration and replication in situ, herein, for the first time, we publicize the key points of actualizing this technology. also, we publicized the technology procedures and the frame constitute of life substances. we bilieve this is a big contribution to human science

    本研究報告，重點報道了組織器官的原位再生復制的臨床程序，報道了組織潛能再生細胞的發現和存在，以及該細胞的增殖分化和形成組織器官的變化規律.以燒傷后皮膚組織器官的原位再生復制為模型，研究出了體外組織潛能再生細胞復制組織器官的培養方法;以體外組織器官的復制為模型，建立了尋找原位組織器官再生復制所需生命物質的方法和技術.本研究，首先按人體的器官功能，分解為206個功能單位，確立了所復制的人體器官中的組織功能單位為組織器官，從而建立了原位組織器官再生復制的組織學基礎.為了驗證組織潛能再生細胞的再生潛能，建立了皮膚器官原位再生的實體臨床跟蹤技術，同時又建立了能代表有關器官功能類別的代表組織器官的原位和體外復制模型，以多組織器官的成功復制確定潛能再生細胞的作用，確定生命研究再生物質的重要性，確定組織器官原位再生復制的可行性，確定了組織器官原位再生復制的生命科學研究和醫學進步的重大應用價值，同時展示了用此方法和技術攻克癌癥的前景.本研究報告，以近二百幅多個組織器官原位和體外再生復制的實體圖片，展示了潛能再生細胞復制的組織器官和大器官司實體;展示了細胞再生復制器官的全過程.真實的報告了組織器官原位再生復制的成果.所公布的主要成果為:皮膚器官的原位再生復制;胃腸黏膜組織器官的原位和體外再生復制;毛囊組織器官的原位和體外再生復制;神經組織器官的原位復制;胰腺組織器官的體外復制;骨髓組織的體外復制;腎小球小管組織器官的體外復制;心肌的體外復制等.為了讓更多的人學會和掌握組織器官原位再生復制技術，本報告首次公布實施技術的重要環節和技術流程;首次公布了生命再生物質的框架和組成.作者自費研究成果對人類生命科學的一大貢獻
  3. Treatment of avascular necrosis of femoral head by implanting a composite of bone marrow, bone morphogenetic protein, and noncelluar tissue engineered bone allograft

    非細胞型組織工程化異體骨復合骨形態發生蛋白和紅骨髓治療股骨頭缺血性壞死
  4. Alternatively, they could generate healthy specialized cells from patients who had donated their genetic material, and transplant them into tissues - - without the risk of prompting immune rejection - - to treat failing hearts, neurological diseases such as parkinson ' s disease and amyotrophic lateral sclerosis, spinal cord injury and diabetes

    上述二者中，他們可從被診為患遺傳疾病的病人中生成指定的健康細胞，並將其移植培養為組織不存在排斥免疫方面的風險可治療心臟衰竭，神經疾病如帕金森癥，肌萎縮性（脊髓）側索硬化癥，骨髓病癥和糖尿病。
  5. The application of immunocytochemical technique in the bone marrow sections in patients with myelodysplastic syndromes

    免疫組織化學技術在骨髓增生異常綜合征骨髓病理中的應用
  6. So in our experiment, we applied with freezing and drying bone and bone marrow stem cells ( bmsc ) as cellular seeds. in these conditions, freezing and drying bones provided fine interspaces structure and good adhesive and grow conditions. at the same time, bmsc which transfected vascular endothelial growth factors ( vegf ) as cellular seeds provided the seeds and stimulating factors

    目前，深凍骨已商品化，免疫排斥反應罕見發生，故本實驗以凍干松質骨作為基質材料、轉染有血管內皮細胞生長因子（ vegf ）的骨髓基質幹細胞（ bmsc ）為種子細胞，這樣既保持了骨組織優良的空間結構，又提供了種子細胞和血管化的刺激因子。
  7. Autoimmune disorders such as multiple sclerosis and rheumatoid arthritis arise when white blood cells of the immune system, which arise from the bone marrow, attack the body ' s own tissues

    自體免疫疾病的產生，像是多發性硬化癥或風濕性關節炎，是因為源自骨髓的免疫系統的白血球攻擊了自己體內的組織。
  8. Endothelial progenitor cells ( epcs ) originating from bone marrow play a significant role in neovascularization of ischemic tissues and also in re - endothelialization of damaged blood vessels

    血管內皮祖細胞起源於骨髓，對于缺血組織的血管新生和損傷血管的復內皮化起著很重要的作用。
分享友人
分享到 Line

分享到臉書